Skip to main content

E-book

Trends shaping pharma strategy in 2026

How should pharma manufacturers strategically evolve as the industry shifts? Get expert insights from Advisory Board and Optum® Life Sciences.

How to prioritize what matters

Each year, Advisory Board and Optum® Life Sciences experts analyze the trends shaping the future for life sciences organizations. This year’s e-book spotlights 5 critical shifts that require strategic consideration in 2026. These shifts call for a more adaptive, data-informed and stakeholder-aware approach to strategy. 

Related healthcare insights

View all

Case study

Identifying patients' bone fracture risk

Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.

Article

Catalyze the use of RWE in life sciences

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.

Article

Integrated RWD: The key to accelerating innovation

To maximize the value of clinical innovations, you need dimensional, robust data. Learn about leveraging integrated cost and clinical data.